The "AML SUMMIT: Discovering AML's New Horizons" presents an opportunity to delve into cutting-edge advancements in Acute Myeloid Leukemia (AML) management. With a lineup of four experts including two Belgian (Prof. Dr. Anguille and Dr. Selleslag) and two international experts (Prof. Dr. Bullinger and Prof. Dr. Mohty), the summit promises to deliver invaluable insights on haplotransplant, CART therapy, genomics, and more.
Accreditation will be requested by Roularta HealthCare.
When
Monday, September 2, 2024 · 7:00 p.m.
CEST (GMT +2:00)